Health Technology · Pharmaceuticals: Other · NSE: AMRUTANJAN · data 2026-10-09
Amrutanjan Health Care Limited
Health check: Average (5.8/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹508.9
Market cap
₹1,474 cr
P/E
27.3
P/B
—
ROE
16.6%
ROCE
17.9%
Debt / equity
0
Dividend yield
0.97%
1-year return
-27.8%
52-week high
₹760.15
52-week low
₹476.5
Operating margin
11.6%
Growth
| Revenue (last 12 months) | ₹511 cr |
| Net profit (last 12 months) | ₹54 cr |
| Sales growth, 3 years (yearly) | 9.8% |
| Profit growth, 3 years (yearly) | 13.3% |
Similar companies
Sudeep Pharma Limited (SUDEEPPHRM) · Shri Ahimsa Naturals Limited (SHRIAHIMSA) · Influx Healthtech Limited (INFLUX) · Lyka Labs Limited (LYKALABS) · Sat Kartar Life Limited (SATKARTAR)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open AMRUTANJAN in NSE Scanner →